Metrics

Safety and Preliminary Efficacy of Intranasal Insulin for Cognitive Impairment in Parkinson Disease and Multiple System Atrophy (v1.0)

Unique Registered Project Views

232

Current Version

232

All Versions
Total number of unique registered users who have viewed this project. Views tracked since March 2022.

Views Over Time

Month Unique Viewers
October 2026 3
September 2026 5
August 2026 6
July 2026 1
June 2026 4
May 2026 6
April 2026 5
March 2026 3
February 2026 3
January 2026 4
December 2025 6
November 2025 2

Back to Safety and Preliminary Efficacy of Intranasal Insulin for Cognitive Impairment in Parkinson Disease and Multiple System Atrophy v1.0